div class=ts-pagebuttonPage 1button div class=ts-image amp-img class=ts-thumb alt=Page 1: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails1jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 2button div class=ts-image amp-img class=ts-thumb alt=Page 2: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails2jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 3button div class=ts-image amp-img class=ts-thumb alt=Page 3: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails3jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 4button div class=ts-image amp-img class=ts-thumb alt=Page 4: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails4jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 5button div class=ts-image amp-img class=ts-thumb alt=Page 5: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails5jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 6button div class=ts-image amp-img class=ts-thumb alt=Page 6: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails6jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 7button div class=ts-image amp-img class=ts-thumb alt=Page 7: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails7jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 8button div class=ts-image amp-img class=ts-thumb alt=Page 8: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails8jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 9button div class=ts-image amp-img class=ts-thumb alt=Page 9: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails9jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 10button div class=ts-image amp-img class=ts-thumb alt=Page 10: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails10jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 11button div class=ts-image amp-img class=ts-thumb alt=Page 11: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails11jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 12button div class=ts-image amp-img class=ts-thumb alt=Page 12: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails12jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 13button div class=ts-image amp-img class=ts-thumb alt=Page 13: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails13jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 14button div class=ts-image amp-img class=ts-thumb alt=Page 14: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails14jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 15button div class=ts-image amp-img class=ts-thumb alt=Page 15: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails15jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 16button div class=ts-image amp-img class=ts-thumb alt=Page 16: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails16jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 17button div class=ts-image amp-img class=ts-thumb alt=Page 17: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails17jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 18button div class=ts-image amp-img class=ts-thumb alt=Page 18: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails18jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 19button div class=ts-image amp-img class=ts-thumb alt=Page 19: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails19jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 20button div class=ts-image amp-img class=ts-thumb alt=Page 20: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails20jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 21button div class=ts-image amp-img class=ts-thumb alt=Page 21: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails21jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 22button div class=ts-image amp-img class=ts-thumb alt=Page 22: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails22jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 23button div class=ts-image amp-img class=ts-thumb alt=Page 23: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails23jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 24button div class=ts-image amp-img class=ts-thumb alt=Page 24: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails24jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 25button div class=ts-image amp-img class=ts-thumb alt=Page 25: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails25jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 26button div class=ts-image amp-img class=ts-thumb alt=Page 26: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails26jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 27button div class=ts-image amp-img class=ts-thumb alt=Page 27: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails27jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 28button div class=ts-image amp-img class=ts-thumb alt=Page 28: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails28jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 29button div class=ts-image amp-img class=ts-thumb alt=Page 29: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails29jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 30button div class=ts-image amp-img class=ts-thumb alt=Page 30: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails30jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 31button div class=ts-image amp-img class=ts-thumb alt=Page 31: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails31jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 32button div class=ts-image amp-img class=ts-thumb alt=Page 32: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails32jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 33button div class=ts-image amp-img class=ts-thumb alt=Page 33: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails33jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 34button div class=ts-image amp-img class=ts-thumb alt=Page 34: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails34jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 35button div class=ts-image amp-img class=ts-thumb alt=Page 35: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails35jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 36button div class=ts-image amp-img class=ts-thumb alt=Page 36: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails36jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 37button div class=ts-image amp-img class=ts-thumb alt=Page 37: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails37jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 38button div class=ts-image amp-img class=ts-thumb alt=Page 38: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails38jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 39button div class=ts-image amp-img class=ts-thumb alt=Page 39: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails39jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 40button div class=ts-image amp-img class=ts-thumb alt=Page 40: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails40jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 41button div class=ts-image amp-img class=ts-thumb alt=Page 41: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails41jpg width=142 height=106 layout=responsive amp-img divdivdiv class=ts-pagebuttonPage 42button div class=ts-image amp-img class=ts-thumb alt=Page 42: P16-253 protocol pdfa - ClinicalTrialsgovP16-253 Protocol Abstract Real World Study of the Effectiveness of Paritaprevirr — Ombitasvir + Dasabuvir without Ribavirin in Patients src=https:reader030vdocumentsnetreader030viewer20220410105eba1cfd28087646b009fb27html5thumbnails42jpg width=142 height=106 layout=responsive amp-img divdiv